ONTX

15.31

8.05% -1.3409

Dopo l'orario di chiusura: 14.45 -0.8611 -5.62%

Onconova Therapeutics Inc (ONTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$16.65

Aprire:

$16.91

Volume 24 ore:

4,658

Relative Volume:

1.00

Capitalizzazione di mercato:

$20.90M

Reddito:

$226.00K

Utile/perdita netta:

$-20.18M

Rapporto P/E:

-15.78

EPS:

-0.97

Flusso di cassa netto:

$-17.40M

1 W Prestazione:

-13.14%

1M Prestazione:

-40.58%

6M Prestazione:

+1,438%

1 anno Prestazione:

+1,438%

Intervallo 1D:

$14.14

$16.91

Intervallo di 1 settimana:

$14.14

$20.60

Portata 52W:

$14.14

$43.14

Onconova Therapeutics Inc Stock (ONTX) Company Profile

Nome

Onconova Therapeutics Inc

Settore

Healthcare (1074)

Industria

Biotechnology (599)

Telefono

267 759 3680

Indirizzo

12 Penns Trail, Newtown, PA

Dipendente

Cinguettio

@Onconova_ONTX

Prossima data di guadagno

2024-05-13

Ultimi documenti SEC

ONTX's Discussions on Twitter

Compare ONTX vs VRTX, REGN, ARGX, RVMD, ALNY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ONTX Onconova Therapeutics Inc	15.31	20.90M	226.00K	-20.18M	-17.40M	-0.97
VRTX Vertex Pharmaceuticals Inc	479.00	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	667.17	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	888.82	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	188.07	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	278.40	36.28B	4.29B	577.22M	641.34M	4.2086

Onconova Therapeutics Inc Stock (ONTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-03	Iniziato	H.C. Wainwright	Buy
2022-03-01	Iniziato	Ladenburg Thalmann	Buy
2021-05-18	Iniziato	Guggenheim	Buy
2018-03-01	Reiterato	H.C. Wainwright	Buy
2018-01-17	Downgrade	Maxim Group	Buy → Hold
2017-10-09	Iniziato	H.C. Wainwright	Buy
2017-04-27	Iniziato	Laidlaw	Buy
2015-07-01	Aggiornamento	Piper Jaffray	Neutral → Overweight
2015-05-05	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Onconova Therapeutics Inc Borsa (ONTX) Ultime notizie

May 26, 2026

TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors - PR Newswire

Dec 22, 2025

Oct 20, 2025

Oncology Clinical Trials Market Size, Share, Growth, Analysis, 2034 - Straits Research

Oct 20, 2025

Oct 06, 2025

PI3K Inhibitors Clinical Trials Analysis 2025: Pipeline Analysis, Competitive Landscape, Emerging Therapies, Companies, and Future Outlook by DelveInsight - The Globe and Mail

Oct 06, 2025

Sep 25, 2025

Annovis Appoints Mark Guerin as Chief Financial Officer - citybiz

Sep 25, 2025

Jun 03, 2025

Rigosertib Shows Promise in EB-Associated Skin Cancer - Medscape

Jun 03, 2025

Apr 24, 2025

ONTX Stock Price, News & Analysis - Stock Titan

Apr 24, 2025

Dec 30, 2024

Huadong Medicine and Synerk to jointly develop siRNA drug - BioWorld MedTech

Dec 30, 2024

Apr 27, 2024

Onconova Therapeutics (NASDAQ: ONTXW)Share Price - intelligentinvestor.com.au

Apr 27, 2024

Apr 10, 2024

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com

Apr 10, 2024

Apr 06, 2024

Traws Pharma (TRAW) Stock Price, News & Analysis - MarketBeat

Apr 06, 2024

Apr 04, 2024

10 High-Volume Penny Stocks and Trading Strategies - StocksToTrade

Apr 04, 2024

Apr 02, 2024

Onconova and Trawsfynydd merge to form Traws Pharma By Investing.com - Investing.com UK

Apr 02, 2024

Mar 21, 2024

PI3K Inhibitors Clinical Trial Pipeline Experiences - GlobeNewswire

Mar 21, 2024

Mar 09, 2024

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance

Mar 09, 2024

Oct 25, 2023

Zim Doctor Appointed Chief Medical Officer in UK - ZimEye

Oct 25, 2023

Apr 21, 2023

Penny Stocks To Buy Now? 5 With Big News Today - PennyStocks.com

Apr 21, 2023

Feb 07, 2023

Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting - Yahoo Finance

Feb 07, 2023

Dec 19, 2022

Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz

Dec 19, 2022

Aug 11, 2022

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022 - The Globe and Mail

Aug 11, 2022

Aug 04, 2022

Corgi Onto 2X Daily ETF (ONTX-A) Stock Price and News - The Globe and Mail

Aug 04, 2022

May 12, 2022

Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug - Yahoo Finance

May 12, 2022

Mar 22, 2022

Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy - EMJ

Mar 22, 2022

Sep 23, 2021

ONTX stock dives 16%, DVAX stock in green after clinical data - Kalkine Media

Sep 23, 2021

Sep 22, 2021

What's going on in today's pre-market session - ChartMill

Sep 22, 2021

Jun 01, 2021

Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer - GlobeNewswire

Jun 01, 2021

May 20, 2021

Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist

May 20, 2021

Mar 23, 2021

Onconova Therapeutics (ONTX) Stock Live Price, Chart & News - CoinCodex

Mar 23, 2021

Feb 17, 2021

ONTX Stock: Why Biopharma Onconova Therapeutics Is Shooting Higher Today - InvestorPlace

Feb 17, 2021

Jan 09, 2021

PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - Inquirer.com

Jan 09, 2021

Jan 06, 2021

Novel CDK4/6 Inhibitor ON 123300 Receives Green Light to Move Into Phase 1 Testing in Relapsed/Refractory Advanced Cancers - OncLive

Jan 06, 2021

Dec 02, 2020

Onconova Therapeutics Stock Price Forecast. Should You Buy ONTX? - StockInvest.us

Dec 02, 2020

Aug 31, 2020

Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz

Aug 31, 2020

Aug 25, 2020

Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights

Aug 25, 2020

Aug 11, 2020

Are These On Your List Of Penny Stocks To Trade This Week? - PennyStocks.com

Aug 11, 2020

Jun 11, 2020

Penny Stocks To Watch Before Next Week; 1 Up Over 370% In June 2020 - PennyStocks.com

Jun 11, 2020

Apr 24, 2020

Onconova Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - Reuters

Apr 24, 2020

Dec 09, 2019

ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX) - ChartMill

Dec 09, 2019

Jan 16, 2019

Bucks County biopharm firm names new CEO - The Business Journals

Jan 16, 2019

Jan 15, 2019

Onconova Therapeutics Announces New CEO Appointment - Global Banking & Finance Review

Jan 15, 2019

May 09, 2018

Hedge Fund and Insider Trading News: Michael Novogratz, Ray Dalio, Onconova Therapeutics Inc. (ONTX), Cerecor Inc (CERC), Spirit of Texas Bancshares Inc (STXB), L3 Technologies Inc (LLL), and More - Insider Monkey

May 09, 2018

Mar 05, 2018

Onconova Therapeutics Announces License Agreement With Pint Pharma To Commercialize Rigosertib - Reuters

Mar 05, 2018

Feb 12, 2018

Onconova Therapeutics Announces Closing of $10 Million - GlobeNewswire

Feb 12, 2018

Dec 28, 2017

Onconova Therapeutics to Present at Biotech Showcase in January - GlobeNewswire

Dec 28, 2017

Nov 20, 2017

Onconova Therapeutics,Inc. (NASDAQ:ONTX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - marketexclusive.com

Nov 20, 2017

Nov 16, 2017

Onconova Therapeutics Announces Data on Improved - GlobeNewswire

Nov 16, 2017

Nov 10, 2017

Onconova Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire

Nov 10, 2017

Nov 09, 2017